Research
Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data
Paul W. Armstrong, Wei-Ching Chang, Lars Wallentin, Patrick Goldstein, Christopher B. Granger, Kris Bogaerts, Thierry Danays, Frans Van de Werf and ; for the ASSENT-3 and ASSENT-3 PLUS Investigators
CMAJ May 09, 2006 174 (10) 1421-1426; DOI: https://doi.org/10.1503/cmaj.051410
Paul W. Armstrong
Wei-Ching Chang
Lars Wallentin
Patrick Goldstein
Christopher B. Granger
Kris Bogaerts
Thierry Danays
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data
Paul W. Armstrong, Wei-Ching Chang, Lars Wallentin, Patrick Goldstein, Christopher B. Granger, Kris Bogaerts, Thierry Danays, Frans Van de Werf
CMAJ May 2006, 174 (10) 1421-1426; DOI: 10.1503/cmaj.051410
Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data
Paul W. Armstrong, Wei-Ching Chang, Lars Wallentin, Patrick Goldstein, Christopher B. Granger, Kris Bogaerts, Thierry Danays, Frans Van de Werf
CMAJ May 2006, 174 (10) 1421-1426; DOI: 10.1503/cmaj.051410
Jump to section
Related Articles
Cited By...
- Antithrombotic Therapy in the Elderly
- Part 10: Acute Coronary Syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
- Part 9: Acute Coronary Syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations
- Low-molecular-weight heparins as adjunctive therapy to thrombolytics: extracting the best data.